Literature DB >> 9065742

Scavenger receptor-mediated delivery of antisense mini-exon phosphorothioate oligonucleotide to Leishmania-infected macrophages. Selective and efficient elimination of the parasite.

G Chaudhuri1.   

Abstract

Targeted delivery of a 17-mer antisense phosphorothioate oligodeoxyribonucleotide, complementary to the common 5'-end of every mRNA of the parasite cells, to the phagolysosomes of cultured murine macrophages infected with Leishmania mexicana amazonensis selectively and efficiently eliminated the parasite cells without causing any detectable harm to the host cells. The antisense mini-exon oligonucleotide (ASM) was encapsulated into liposomes coated with maleylated bovine serum albumin (MBSA), the artificial ligand for macrophage scavenger receptors. MBSA-coating of the liposomes allowed specific binding of the liposomes to the macrophages, their receptor-mediated uptake, and subsequent degradation of the liposomes inside macrophage phagolysosomes to release ASM. When incubated with Leishmania-infected macrophages, MBSA-liposome-encapsulated ASM (10 microM) was able to kill >90% of the parasites within 5 hr as compared with 20% killing within this time period by free ASM. Oligonucleotides with complementary nucleotide sequence or with the same base composition as ASM but scrambled sequence had no antileishmanial effect under the conditions of the assay. This study reflects the efficacy of scavenger-receptor-mediated delivery of antisense phosphorothioate oligos in killing intraphagolysosomal pathogens.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9065742      PMCID: PMC3088079          DOI: 10.1016/s0006-2952(96)00763-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

Review 1.  Receptor-mediated endocytosis of macromolecular conjugates in selective drug delivery.

Authors:  S K Basu
Journal:  Biochem Pharmacol       Date:  1990-11-01       Impact factor: 5.858

2.  Atherosclerosis. Scavenging for receptors.

Authors:  M S Brown; J L Goldstein
Journal:  Nature       Date:  1990-02-08       Impact factor: 49.962

3.  Scavenger-receptor-mediated delivery of daunomycin elicits selective toxicity towards neoplastic cells of macrophage lineage.

Authors:  A Mukhopadhyay; B Mukhopadhyay; R K Srivastava; S K Basu
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

4.  Selective delivery of drugs to macrophages through a highly specific receptor. An efficient chemotherapeutic approach against leishmaniasis.

Authors:  G Chaudhuri; A Mukhopadhyay; S K Basu
Journal:  Biochem Pharmacol       Date:  1989-09-15       Impact factor: 5.858

5.  Receptor-mediated drug delivery to macrophages in chemotherapy of leishmaniasis.

Authors:  A Mukhopadhyay; G Chaudhuri; S K Arora; S Sehgal; S K Basu
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

Review 6.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

7.  Antisense phosphorothioate oligonucleotides: selective killing of the intracellular parasite Leishmania amazonensis.

Authors:  C Ramazeilles; R K Mishra; S Moreau; E Pascolo; J J Toulmé
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-16       Impact factor: 11.205

8.  Functional complementation of an Escherichia coli ribonuclease H mutation by a cloned genomic fragment from the trypanosomatid Crithidia fasciculata.

Authors:  A G Campbell; D S Ray
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

Review 9.  Antisense oligodeoxynucleotides.

Authors:  C A Stein; R Narayanan
Journal:  Curr Opin Oncol       Date:  1994-11       Impact factor: 3.645

Review 10.  The role of pH and temperature in the development of Leishmania parasites.

Authors:  D Zilberstein; M Shapira
Journal:  Annu Rev Microbiol       Date:  1994       Impact factor: 15.500

View more
  10 in total

1.  Molecular characterization of a human BRCA2 homolog in Leishmania donovani.

Authors:  Smita Misra; Mack Hall; Gautam Chaudhuri
Journal:  J Parasitol       Date:  2005-12       Impact factor: 1.276

2.  Oligonucleotides tethered to a short polyguanylic acid stretch are targeted to macrophages: enhanced antiviral activity of a vesicular stomatitis virus-specific antisense oligonucleotide.

Authors:  V Prasad; S Hashim; A Mukhopadhyay; S K Basu; R P Roy
Journal:  Antimicrob Agents Chemother       Date:  1999-11       Impact factor: 5.191

3.  Down-regulation of 7SL RNA expression and impairment of vesicular protein transport pathways by Leishmania infection of macrophages.

Authors:  Smita Misra; Manish K Tripathi; Gautam Chaudhuri
Journal:  J Biol Chem       Date:  2005-06-14       Impact factor: 5.157

4.  Cationic liposome-encapsulated antisense oligonucleotide mediates efficient killing of intracellular Leishmania.

Authors:  R Chakraborty; D Dasgupta; S Adhya; M K Basu
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

5.  Increased efficacy of antileishmanial antisense phosphorothioate oligonucleotides in Leishmania amazonensis overexpressing ribonuclease H.

Authors:  M Mishra; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-02-15       Impact factor: 5.858

6.  Leishmania-induced repression of selected non-coding RNA genes containing B-box element at their promoters in alternatively polarized M2 macrophages.

Authors:  Anitra L Farrow; Tanu Rana; Mukul K Mittal; Smita Misra; Gautam Chaudhuri
Journal:  Mol Cell Biochem       Date:  2010-12-17       Impact factor: 3.396

7.  A type II ribonuclease H from Leishmania mitochondria: an enzyme essential for the growth of the parasite.

Authors:  Smita Misra; Jabbar Bennett; Yeshitila N Friew; Junaid Abdulghani; Charletha V Irvin-Wilson; Manish K Tripathi; Shauntae Williams; Minu Chaudhuri; Gautam Chaudhuri
Journal:  Mol Biochem Parasitol       Date:  2005-10       Impact factor: 1.759

8.  Enhanced activity of antisense phosphorothioate oligos against leishmania amastigotes: augmented uptake of oligo, ribonuclease H activation, and efficient target intervention under altered growth conditions.

Authors:  M Mishra; J M Porter-Kelley; P K Singh; J R Bennett; G Chaudhuri
Journal:  Biochem Pharmacol       Date:  2001-09-01       Impact factor: 5.858

Review 9.  Carriers for the targeted delivery of aerosolized macromolecules for pulmonary pathologies.

Authors:  Nashwa Osman; Kan Kaneko; Valeria Carini; Imran Saleem
Journal:  Expert Opin Drug Deliv       Date:  2018-07-26       Impact factor: 6.648

Review 10.  Innovations in oligonucleotide drug delivery.

Authors:  Melanie A Lysik; Susanna Wu-Pong
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.